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Abstract: In the last two decades, a group of proteins whose mutations are associated with a disease
manifested by episodes of muscle weakness (periodic paralysis), changes in heart rhythm
(arrhythmia), and developmental abnormalities has been under constant study. This malady is known
as Andersen–Tawil syndrome, with ~60% of cases of this syndrome being caused by 16 mutations in
the KCNJ2 gene [UniProt ID: P63252-01—P63252-17]. In this work, we present a computational
study designed to obtain a fingerprint of Andersen–Tawil mutated proteins and differentiate them
from mutated proteins associated with Brugada syndrome and from functional groups of proteins
belonging to APD3, UniProt, and CPPsite databases. We show here that Andersen–Tawil mutated
proteins are characterized by specific features that can be used to differentiate, with a high level
of certainty (90%), proteins carrying these mutations from similar functional groups, such as
mutated proteins associated with Brugada syndrome, and from different functional protein and
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peptide groups, such as antimicrobial peptides, Cell-Penetrating Peptides, and intrinsically
disorder proteins. Therefore, our main results allow us to conjecture that it is possible to identify
the group of the Andersen–Tawil mutated proteins by their "PIM profile". Furthermore, when we
applied this "fingerprint PIM profile" on the UniProt database, we observed that one protein
found in humans [UniProt ID: Q9NZV8], and six of all ―reviewed‖ proteins found in living
organisms, possess a very similar PIM profile as the Andersen–Tawil mutated protein group. The
bioinformatics ―fingerprint‖ of the Andersen–Tawil mutated proteins was retrieved using the inhouse bioinformatics system named Polarity Index Method® and supported—at residues level—
by the algorithms for the prediction of intrinsic disorder predisposition, such as PONDR® FIT,
PONDR® VLXT, PONDR® VSL2, PONDR® VL3, FoldIndex, IUPred, and TopIDP.
Keywords: Andersen–Tawil syndrome; bioinformatics; channelopathies; high performance
computing; Ion channels; PIM profile; proteins; mutations; structural bioinformatics

1

Introduction

Andersen–Tawil syndrome (ATS) [1,2] is a disease characterized by: skeletal abnormalities,
periodic muscle paralysis and the presence of specific ventricular arrhythmias that may predispose to
sudden cardiac death. Some afflicted individuals had characteristic developmental abnormalities and
might possess distinctive physical features, such as scoliosis, low-set or malformed ears, short stature,
orbital hypertelorism; i.e., an increased distance between the eyes, a broad forehead, micrognathia,
small hands and feet, and loose joints. ATS is considered as a rare hereditary multisystem disorder,
which is also known as long QT syndrome type 7 (LQT7) [3]. This syndrome has an estimated
prevalence of approximately 1/1,000,000 [4,5]. Although the genetic basis of this disease in 40% of
cases is unknown, more than 60% of the identified cases of this rare genetic disease are associated
with mutations in the KCNJ2 gene [6], which encodes an inward rectifier potassium channel 2,
Kir2.1 protein. The predominant form of this channelopathy is sporadic or non-hereditary, which
means that at least 30% of the syndrome-associated mutations in the KCNJ2 gene are de novo [7–11],
but ATS can also be inherited in an autosomal dominant fashion [8,10].
The Kir2.1 protein produces a strong inward rectification, preferentially passing potassium ions
into the cell. It belongs to the Kir family of potassium channels and, being preferentially expressed in
the heart and nervous tissues, is involved in stabilizing the resting membrane potential [12].
Topologically, human Kir2.1 protein (UniProt ID: P63252) is characterized by the presence of two αhelical transmembrane regions (M1 and M2, residues 82–106 and 157–178) separated by a
regulatory segment (residues 107–156) containing the intramembrane pore-forming loop (H5 or Ploop, residues 129–147) connected to the M1 and M2 transmembrane regions via extracellular
linkers (residues 107–128 and 148–156). The N- and C-terminal regions of this protein (residues 2–
81 and 179–427, respectively) are located intracellularly. The active channels are formed by
heterotetramerization or homotetramerization of four Kir2.x subunits to form a tetramer [12]. The K+
selectivity of the Kir2.1 channel is determined by its intramembrane pore-forming loop containing
the G–Y–G (Gly-Tyr-Gly) signature sequence [12]. The vast majority of the Kir2.1 mutations
associated with ATS are loss-of-function mutations located within the N- and C-terminal tails of this
protein [13]. In fact, from the 66 mutations described in the literature so far [13], which include
Mathematical Biosciences and Engineering
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missense mutations (58 mutations of 36 different residues), short deletions, nonsense mutations and
an insertion, 15 and 34 mutations are found within the N- and C-terminal regions, respectively, of the
Kir2.1 protein. However, other parts of this protein are also affected by the ATS-associated mutations,
with M1, P-loop, and M2 containing 6, 8 and 3 such mutations, respectively [13].
In this work, we aim to contribute, from a computational viewpoint, to a better understanding of
the 16 ATS mutated proteins extracted from the UniProt database on September 2017 [UniProt ID:
P63252-01—P63252-17]—these 16 redundant proteins—it means that one protein (variant) can
appear several times, equivalent to 13 non-redundant mutated proteins (Table 1)—by training a
computational system, the Polarity Index Method® (PIM) [14], with the ATS mutated proteins taken
from the UniProt database [15]. The PIM profile obtained from the PIM system in this study was
compared to the PIM profile of mutated proteins associated with Brugada syndrome (BrS) [16]
(since BrS and ATS are both channelopathies, where these BrS-related mutations affect the sodium
channel, while the ATS-related mutation affect the potassium channel), and with the PIM profiles of
the antimicrobial proteins associated with bacteria (Gram–positive/Gram–negative), fungi, viruses,
and cancer, whose sequences were extracted from the UniProt and APD3 [17] databases. The ATS
mutated proteins were also compared with the Cell-Penetrating Peptides (CPP) with and without
endocytic uptake mechanism from the CPPsite database [18] and with proteins containing different
levels of intrinsic disorder, such as completely disordered and partially disordered [19] (see Table 1).
Then, from the UniProt database [http://www.UniProt.org/help/retrieve_sets], we extracted
9,023 ―reviewed‖ human proteins (September 5th, 2017), and 468,939 ―reviewed‖ proteins found in
other living organisms, and calculated their PIM profiles. Next, the PIM profile of each of these
proteins were compared with the PIM profile obtained for ATS mutated proteins. The PIM system
was able to identify and discriminate, with a high level of certainty (90%), the ATS-mutated proteins
from the other protein groups analyzed in this study. This selection of protein sets aims to validate
the discriminative capacity of the PIM profile metric, to then use the PP characteristic of ATS
mutated proteins, and look among other protein groups for proteins with the same PIM profile.
We hypothesize that proteins with similar PIM profiles should have similar functions.
The efficiency of the PIM system was verified by comparison of the proportion of
accepted/rejected proteins from two comparisons: first, the ATS mutated proteins and BrS
mutated proteins with respect to the real proportion of corresponding proteins in those groups;
and second, from the ATS mutated proteins and ATS proteins with respect to the real proportion
of corresponding proteins in those groups. These analyses were performed using the
nonparametric two-sided Kolmogorov–Smirnov test (2.6 Statistical test section).
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Table 1. Protein sets.
#

Source

Access date

Groups

Debugging process

a

ATS

Redundant
NonMutated
sequences
redundant proteins
in PIM format sequences
in PIM
format

b

c
Intrinsic disorder
CPP
propensity
Completely Partially With endocytic
Without
disordered ordered uptake
endocytic uptake
mechanism
mechanism

1

UniProt [15]

Sep 5th, 2017

ATS proteins

8

7

0‡

6@

3@

0Σ

0Σ

2

UniProt [15]

Sep 5th, 2017

ATS mutated proteins

16

13

13‡

10@

1@

0Σ

0Σ

3

UniProt [15]

Sep 5th, 2017

BrS proteins

36

20

0†

15

12

0

1

4

UniProt [15]

Sep 5th, 2017

BrS mutated proteins

4388

824

0†

664

505

0

5

5

APD3 [17]

Aug 16th, 2017

Peptides associated to bacteria

1117

975

0†

519

590

249

105

6

APD3 [17]

Aug 16th, 2017

Peptides associated to fungi

283

269

0†

125

117

28

11

7

APD3 [17]

Aug 16th, 2017

Peptides associated to virus

44

44

0†

22

22

5

1

8

APD3 [17]

Aug 16th, 2017

Peptides associated to cancer

23

22

0†

13

12

2

1

9

UniProt [15]

Sep 5th, 2017

Peptides associated to bacteria

658

581

0†

299

279

69

26

10 UniProt [15]

Sep 5th, 2017

Peptides associated to fungi

20

20

0†

16

9

0

0

11 UniProt [15]

Sep 5th, 2017

Peptides associated to virus

93

93

0†

60

37

0

0

12 UniProt [15]

Sep 5th, 2017

Peptides associated to cancer

206

204

0†

28

18

0

0

Completely disordered proteins 106
Partially ordered proteins
152

50
149

0†
0†

46
56

18
132

2
9

0
2

13 [19]
14 [19]

Continued on next page
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#

Source

Access date

Groups

Debugging process

a

ATS

Redundant
NonMutated
sequences
redundant proteins
in PIM format sequences
in PIM
format

b

c
Intrinsic disorder
CPP
propensity
Completely Partially With endocytic
Without
disordered ordered uptake
endocytic uptake
mechanism
mechanism

86

0†

35

52

83

39

CPP without endocytic uptake126
mechanism

105

0†

20

43

26

62

Sep 5th, 2017

Gram–positive
"reviewed" proteins

6582

0†

4133

2980

116

60

18 UniProt [15]

Sep 5th, 2017

Gram–positive bacteria
reviewed" proteins

32692

0†

22333

7994

142

109

19 UniProt [15]

Sep 5th, 2017

1782

0†

1107

891

66

27

20 UniProt [15]

Sep 5th, 2017

Gram–negative
bacteria2076
"reviewed" proteins
Gram–negative bacteria "non-142692
reviewed" proteins

123683

1†

99841

68286

543

394

21 APD3 [17]
22 APD3 [17]

Sep 5th, 2017
Sep 5th, 2017

Gram–positive bacteria proteins 472
Gram–negative bacteria proteins 256

408
232

0†
0†

235
122

249
131

73
53

24
32

23 UniProt [15]

Sep 5th, 2017

All ‖reviewed‖ proteins found in9023
humans

8975

1Ω

N/P

N/P

N/P

N/P

24 UniProt [15]

Sep 5th, 2017

All ―reviewed‖ proteins in living558114
organisms

468939

11Ω

N/P

N/P

N/P

N/P

15 CPPsite [18]

Oct 30th, 2017

CPP with
mechanism

16 CPPsite [18]

Oct 30th, 2017

17 UniProt [15]

endocytic

uptake100

bacteria6720
"non-35304

Number of a,b,cproteins (located in columns) found in each of the 24 protein (located in rows) groups, when it was calibrated the PIM system with
whose protein sets. PIM format: numeric substitution of each amino acid from the linear sequence according to its polarity [P +, P–, N, NP] (2.1
PIM profile algorithm section). N/P: Item not processed. See analysis Ω,†,‡,@,Σ in 3 Results section.
Mathematical Biosciences and Engineering
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2.

Materials and method

The PIM system [14] has been used to identify several protein groups in previous studies. However,
we consider it appropriate to describe it in this work (see 2.1 PIM profile algorithm section).
2.1. PIM profile algorithm
The metric of the PIM profile used by the computational PIM system extensively evaluates the
16 interactions observed when reading the linear sequence of a protein by pairs of residues, amino
acid by amino acid, from left to right. The system initially replaces the amino acid sequence with the
corresponding numeric charge-related annotations {P+, P–, N, NP} = {1, 2, 3, 4}, according to this
rule: P+ (polar positively charged) = {H, K, R}; P– (polar negatively charged) = {D, E}; N (polar
neutral) = {C, G, N, Q, S, T, Y} and NP (non-polar) = {A, F, I, L, M, P, V, W}. The 16 possible
incidences are recorded in a 4 × 4 algebraic matrix, or incidence matrix, whose rows and columns
represent these four groups, then the matrix is normalized. The last step is to create a 16-element
vector, placing, from left to right, the position (16 possible positions), in decreasing order taken from
the incidence matrix. This vector constitutes the fingerprint of the group of proteins evaluated.
To
exemplify
this
procedure,
we
take
an
arbitrary
protein
[GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ ] (30 amino acids), according to the
corresponding
numeric
charge-related
annotations,
its
equivalent
is:
[341244114334411134344144414443 ]; that is equivalent in numeric pairs —read from left to
right— to [34, 41, 12, 24, 44, 41,11, 14, 43, 33, 34, 44, 41, 11, 11, 13, 34, 43, 34, 44, 41, 14, 44, 44,
41, 14, 44, 44, and 43] (29 pairs), and its corresponding incidence matrix is shown in (Table 2, AStep). This incidence matrix is normalized –to appreciate the order (Table 2, B-Step), and it
represents its 16 positions as 16-element vector in increasing order (Table 2, C-Step). The elements
of the 16-element vector are assigned, placing in its element 1, the position of the matrix A which
has the higher frequency, to element 2, the position of the matrix A which has the next frequency
with lower value, and so on until, to assign to the last element of the vector the position of the matrix
A with the lower frequency.
Note: In case of two or more equal frequencies in matrix A, it is read from bottom to top, and
from left to right.
The comparison of the PIM profile of a protein, with a target protein—which we will assume is
representative of the searched characteristic (Table 2, C-Step), is done by comparing the their 16element vectors. In summary, the PIM system establishes that if two proteins have similar PIM
profile 14 out of 16 (Table 2, C-step), then both proteins have the same preponderant function.
We provide a workflow of the PIM system (Figure 1), in order to clarify the procedure of this
non-supervised computational system.
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Table 2. Example.
A-Step: Incidence matrix–adding.
P‒

N

NP

P+ 3pos 1 (6)

1pos 2 (10)

1pos 3 (9)

3pos 4 (5)

P‒ 0 pos 5 (16)

0pos 6 (15)

0 pos 7 (14)

1pos 8 (8)

0pos (10) (12)

1pos 11 (7)

4pos 12 (3)

0pos 14 (11)

3pos 15 (4)

7pos 16 (1)

P+

P‒

N

NP

P+

P‒

N

NP

0.033pos 2 (10

0.0333pos 3 (9)

0.100pos 4 (5)

0.0000pos 7 (14)

0.033pos 8 (8)

P+

AGWKDWAKKAGGWLKKKGPGMAK
AALKAAMQ [i,j] =

N

0pos 9 (13)

NP 5pos 13 (2)

B-Step Incidence matrix–weighting.

P+ 0.100pos 1 (6)

P‒ 0.000 pos 5 (16) 0.000pos 6 (15)

AGWKDWAKKAGGWLKKKGPGMAK
AALKAAMQ [i,j] =

N

0.000pos 9 (13) 0.000pos (10) (12) 0.0333pos 11 (7)

NP 0.166pos 13 (2) 0.000pos 14 (11)

0.1000pos 15 (4)

0.133pos 12 (3)
0.233pos 16 (1)

C-Step: Incidence matrix–comparison.
Position

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

a

A [i,j]

16

13

12

15

4

1

11

8

3

2

14

10

9

7

6

5

b

Target [i,j]

16

11

8

6

7

15

12

10

14

5

4

13

9

1

3

2

Similarity

✔

✕

✕

✕

✕

✕

✕

✕

✕

✕

✕

✕

✔

✕

✕

x

Similarities

1

2

A-Step: Number of incidences (in pairs of amino acids) found in the protein
GWKDWAKKAGGWLKKKG PGMAKAALKAAMQ. B-Step: Weighting the incidence matrix. CStep: Comparison of asample protein and btarget protein by position. (✔): The position matches in the
matrices. (✕): The position does not match in the matrices (2.1 PIM profile algorithm section). In
this example, the similarity of asample protein respect to btarget protein occurs in positions: 1, and 13
➡ 2/16 = 12.4%. Note [A-Step and B-step]: Pos 16 (1) means that at position 16 of matrix A, the
highest frequency is found, and placed at position 1 of the vector. Pos 5 (16) means that in position 5
of matrix A, the lowest frequency is found, and is placed at position 16 of the vector. In case of two
or more equal frequency values, the matrix A is read from bottom to top and from right to left of the
matrix.
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Figure 1. Workflow of evaluation of proteins under study by the PIM system (2.1 PIM
profile algorithm section).
2.2. Graphics of PIM profile
The incidence matrices of the ATS mutated proteins and ATS mutated proteins (Figure 2.a)
and BrS mutated proteins versus ATS proteins (Figure 2.b) are represented geometrically as
histograms, since the interactions are expressed as a discrete range, i.e. 16 interactions are
mentioned in the X-axis.
A selected group of proteins identified by the PIM system (see 2.4 Test plan section) was
graphically analyzed, compared only by its differences, with respect to the PIM profile of the
ATS mutated proteins group (Figure 3).
The procedure for obtaining this selected protein group consisted in calculating the PIM
profile of each protein and comparing it with the PIM profile of ATS mutated proteins. We
Mathematical Biosciences and Engineering
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accepted all candidate proteins, whose distance, with respect to each interaction, was less than
1%; i.e., |ATSi – Candidate proteini| < 0.01, where i = 1,...,16 interactions (see 2.1 PIM Profile
algorithm section). After that, we graphically compared proteins in this set with each other (see
Supplementary Materials). The proteins accepted analytically and graphically can be seen in
(Figure 3).

Figure 3. Proximity of the proteins: A3NDB2, A3NZ22, A1V0A6, Q62H74, A2S5D5,
and A3MPB8 (2.4 Test plan section), to the ATS mutated protein group.
2.3. Protein sets preparation
The proteins associated with ATS and Brugada syndrome were extracted from the UniProt
database (Table 1), and the mutated proteins associated with each of these syndromes were extracted
using the Swissknife–SourceForge® software. Note that although 66 ATS-related mutated proteins
Mathematical Biosciences and Engineering
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are described for the Kir2.1 protein in the literature [13], UniProt has information for only about 16
such redundant mutated proteins [UniProt ID: P63252-01 — P63252-17] — equivalent to 13 not
non-redundant proteins (see Table 1). Therefore, our analysis was limited to mutated proteins
annotated in UniProt, and there were tested with the proteins associated with bacteria (Gram–
positive/Gram–negative), fungi, viruses, and cancer were extracted from the UniProt and APD3
databases (Table 1, rows). The CPP with, and without endocytic uptake mechanism, were extracted
from the CPPsite database. The different disorder propensity of protein groups —completely
disordered and partially ordered— were extracted from Table 1 [20]. From UniProt database we
extracted all ―reviewed‖ proteins found in humans, and all ―reviewed‖ proteins found in living
organisms (Table 1, rows). Part of the bioinformatics analysis was based on the proteins mostly
classified as ―reviewed‖, extracted from the UniProt database (Table 1). Since the databases are
constantly updated, the website and date of extraction of each group are stated in Table 1.
2.4. Test plan
In order to identify the coincidences between the graphs, the relative frequencies of the proteins
and mutated proteins associated with ATS were geometrically compared using histograms as
geometric representation (Figure 2). The PIM system was calibrated with the following groups: ATS
mutated proteins, CPP with, and without endocytic uptake mechanism, and intrinsically disordered
proteins: completely disordered and partially ordered (Table 1,6 columns), searching each PIM
profile among the aforementioned groups (Table 1, 24 rows). Finally, the PIM system was calibrated
with the ATS mutated proteins looking for coincidences in the PIM profile among the 468939
―reviewed‖ proteins found in living organisms (Table 1, Ω box), and 9023 ―reviewed‖ proteins
found in humans (Table 1, Ω box) from the UniProt database. The identified proteins in the previous
step (Table 3, row 4) were compared (2.2 Graphics of PIM profile section) graphically (Figure 3)
with the representative PIM profile of the ATS mutated proteins.
Table 3. ATS mutation protein candidates.
# aProtein groups
1 Partially
ordered
proteins
from
Oldfield’s work, 2005 [19]
2 Gram–negative bacteria "non-reviewed"
protein from UniProt database
3 All ‖reviewed‖ proteins found in
humans from UniProt database

b

Similar sequences found in UniProt database
P19793
A0A0F4RG51
Q9NZV8

4 All ―reviewed‖ proteins found in living A0AFU8, B1JIG7, Q66DY2, B2K6Q9,
organisms from UniProt database
Q3YYT6, Q31XQ5 B2TYK2, B6I5F4,
B1IVP8, A8A391, B1XBQ6, C4ZYK2,
B7MYL2, B5Z153, P68067, B7LDH2,
A4IYJ6, Q5NFR4, A0Q713, B2SGC2,
A1WUH1, Q28S09, A3NDB2, A3NZ22,
Q62H74, A2S5D5, A3MPB8, Q4ZNN4,
L0G8Z0, Q0GNN1.

A7FLH5,
P68066,
B7M8J4,
A7ZQ24,
Q14H66,
A1V0A6,
O72736,

a

Proteins identified by PIM system with similar PIM profile to ATS mutated protein group. b100% of
similarity according to UniProt database. Uniprot IDs in bold have very similar PIM profile to ATS
mutated proteins (2.4 Test plan section).
Mathematical Biosciences and Engineering
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2.5. Evaluation of intrinsic disorder predisposition of human Kir2.1 protein
The intrinsic disorder predisposition of the human Kir2.1 protein (UniProt ID: P63252) was
evaluated using the D2P2 platform, which is a database of predicted disorder that represents a
community resource for pre-computed disorder predictions on a large library of proteins from
completely sequenced genomes [21]. In addition to showing the outputs of several disorder
predictors, such as PONDR® VLXT, PONDR® VSL2B, IUPred, PrDOS, ESpritz and PV2, for a
given query protein, the D2P2 database also provides information on the curated sites of various
posttranslational modifications and on the location of predicted disorder-based potential binding sites
(MoRF) [22] (Figure 4).

Figure 4. Evaluation of the functional intrinsic disorder propensity of human Kir2.1 protein (UniProt
ID: P63252) by D2P2 database (http://d2p2.pro/). Here, complementary disorder evaluations together
with some disorder-related functional information are shown. The D2P2 database uses outputs of
several disorder predictors (see differently colored bars at the top of the plot), such as
ESpritz_DisProt, ESpritz_X-ray, and ESpritz_NMR (shown as ESpritz-D, ESpritz-X, and ESpritz-N,
respectively), IUPred_long and IUPred_short (shown as IUPred-l and IUPred-s, respectively), PV2,
PrDOS, PONDR® VSL2B, and PONDR® VLXT. This is complemented with the information on the
location
of
domains
predicted
by
Superfamily
and
Pfam
platforms
(http://supfam.org/SUPERFAMILY/ and https://pfam.xfam.org/, respectively). The level of
agreement between all of the disorder predictors is shown in the middle of the plot as color intensity
in an aligned gradient. The green segments represent disorder that is not found within a predicted
domain, whereas the blue segments are where the disorder predictions intersect the domain
prediction. Positions of disorder-based interactions sites (MoRFs) and sites of curated
posttranslational modifications (phosphorylation) are also shown by yellow blocks with zigzag infill
and by red circles, respectively.
Mathematical Biosciences and Engineering
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2.6. Statistical test
Two Kolmogorov-Smirnov two-sided tests (alpha = 0.01) [23] were applied, counting the
rejections and matches generated by the PIM system. The first test compared the ATS nonredundant mutated proteins with the ATS non-redundant proteins.The second test compared ATS
non-redundant mutated proteins with the BrS non-redundant mutated proteins. The Excel files
with the protein sets, and the Kolmogorov-Smirnov tests can be found in the Supplementary
Materials files.
3.

Results

Figure 4 represents the disorder profile generated by the D2P2 platform for the normal human
Kir2.1 protein (UniProt ID: P63252), mutations in which are associated with ATS. Since Kir2.1
protein is a multi-pass transmembrane protein, it was expected that its transmembrane region
(residues 82–178), which covers transmembrane helices (M1 and M2, residues 82–106 and 157–178)
and a regulatory segment (residues 107–156) containing the intramembrane pore-forming loop (H5
or P-loop, residues 129–147) connected to the M1 and M2 transmembrane helices via extracellular
linkers (residues 107–128 and 148–156), would contain high levels of order, whereas the cytoplasmlocated N- and C-terminal tails (residues 2–81 and 179–427, respectively) would possess noticeable
levels of intrinsic disorder.
This is in agreement with previous studies on transmembrane proteins, which identified a high
prevalence of intrinsic disorder in the intracellular parts of transmembrane proteins [19–21]. In
agreement with these expectations, Figure 4 shows that significant parts of the N- and C-tails are
predicted to contain high levels of intrinsic disorder, whereas the central part of this protein is mostly
ordered. Importantly, both disordered tails might be related to the regulation of the Kir2.1
functionality, since both of them contain phosphorylation sites (Y9, Y242, Y336, Y337, Y341, S342,
Y366, and S425), and since two disorder-based protein–protein interaction regions (residues 366-381
and 406-416), known as MoRF, are located within the C-tail (Figure 4). Importantly, the vast
majority of disease-related mutations in human Kir2.1 protein are located within its N- (C54F, R67W,
D71V, and T75R) and C-terminal tails (P186L, N216H, R218W, G300V, V302M, T305P, and
Δ314SY315), whereas the remaining mutations (V93I, Δ95SWLF98, and D172N) affect transmembrane
helices M1 and M2. These observations indicate that the majority of the ATS-associated mutations
in the Kir2.1 protein might affect regulation of the functionality of this protein.
The graphs of the PIM profile (Figure 2) of the Kir2.1 protein and mutated proteins associated
with ATS coincide only in the interaction [P–, N] (X-axis), with the main differences between both
graphs being located in the interactions on the X-axis: [P+, P+], [P+, P–], [P+, N] and [P+, NP]. When
comparing the PIM profile of ATS, disordered proteins, and CPP (Table 1, columns) among
themselves and with the other groups (Table 1, rows), it was found that the PIM profile of the Kir2.1
protein and its mutated proteins associated with ATS are clearly distinct from other groups (Table 1,
‡ box). The same conclusion was achieved for the other protein groups evaluated in this study (Table
1, † box). When calibrating the PIM system with the PIM profile of CPP (with and without endocytic
uptake mechanism), it was particularly observed that there were no coincidences with the proteins
and mutated proteins associated with ATS (Table 1, Σ box). Also, when calibrating the PIM system
with the PIM profile of completely disordered proteins and partially ordered proteins groups, it was
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observed that there were almost no coincidences with the ATS proteins and ATS mutated proteins
(Table 1, @ box). When the PIM system was calibrated with the ATS mutated proteins and its PIM
profile was compared with the PIM profile of 468939 ―reviewed‖ proteins found in living
organisms, and 9023 ―reviewed‖ proteins found in humans from the UniProt database, we observed
that (Table 2), there are 37 new proteins (Table 3, row 4)—a negligible number of proteins associated
with ATS-associated in that database. These 37 proteins were explored further thorough a
graphical analysis (Figure 3), which allowed to identify a subset of six proteins with very similar
PIM profile: UniProt ID: A3NDB2, A3NZ22, A1V0A6, Q62H74, A2S5D5, and A3MPB8 (Table
3, row 4) in all ―reviewed‖ proteins found in living organisms, and one protein found in humans
(UniProt ID: Q9NZV8) from UniProt database (Table 3, row 3).
The two statistical two-sided tests confirmed (with alpha = 0.01) that the proportion of
proteins accepted/rejected by the PIM system does not correlate with the actual proportion of the
groups of BrS mutated proteins and ATS mutated proteins, and the groups of ATS mutated
proteins and ATS proteins. These results support the conclusion that the PIM profile of each one
of these groups is different (Figure 2).
4.

Discussion

In clinical practice, and we quote explicitly: ―Since the culprit KCNJ2 gene was identified,
locus heterogeneity has been shown in ATS. Kindreds without KCNJ2 mutations are clinically
indistinguishable from those with mutations. Kir2.1 protein is an inward rectifier K+ channel with
important roles in maintaining membrane potential and during the terminal phase of cardiac action
potential repolarisation‖ [20]. From the bioinformatics viewpoint, it was observed that the PIM
profile of the ATS mutated proteins is completely different from the PIM profile of the BrS mutated
proteins (Table 1, ‡ box). Therefore, our data suggest that it is important to orient the computational
algorithms to the group of mutated proteins associated with ATS. In fact, our results indicate that
there are physicochemical variables that can be used to identify this syndrome.
According to the PIM system, there was one protein found in humans [UniProt ID: Q9NZV8]
(Table 3, row 3), and six proteins found in living organisms [UniProt ID: A3NDB2, A3NZ22,
A1V0A6, Q62H74, A2S5D5, and A3MPB8], with PIM profile peculiarities very similar to those
observed for the ATS-associated mutated forms of the Kir2.1 protein. This mutation penetrance value
is high, noticeably exceeding values envisaged by this group (e.g., it surpasses, by a large margin, the
prevalence of mutated proteins in the Brugada syndrome-associated, where 36 redundant proteins
have 4,388 such redundant mutated proteins). Therefore, we consider prudent to search for some of
these candidate proteins in subjects with ATS diagnosis. ATS is a rare condition consisting of
ventricular arrhythmias, and periodic paralysis, affecting in the medium and long term to the carrier,
i.e. it does not compromise the life of the carrier in the short term, in the way that serious respiratory
tract infections, such as Ebola virus or H1N1 influenza would do. However, 16 disease-causing
mutations (66 mutated forms according to the literature [13]) in a single protein is a high number. In
this work, we conducted a bioinformatics analysis that enables a vertical and horizontal study of a
syndrome that is little known.
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Figure 2. PIM profile of ATS (mutated) proteins versus aATS proteins. PIM profile
ATS (mutated) proteins and bBrS (mutated) proteins. The X-axis represents the 16
interactions (2.2 Graphics of PIM profile section).
From a chemical point of view, the PIM system reveals a clear dominance of nonpolar–nonpolar
amino acid interactions in the sequential composition of ATS proteins. A similar observation was also
made in Brugada proteins. When inspecting the nonpolar amino acid groups with the PIM system, it
can be observed that it is formed by aromatic (F, W) and aliphatic amino acids (A, V, L, I, P), which
can contribute to both hydrophobic and Van der Waals interactions crucial for the protein’s tertiary
structure. Therefore, the sequential nonpolar–nonpolar dominance should be echoed in clusters of
nonpolar domains in tertiary structures, entropically enforcing the stability of these proteins. It
is interesting that this seems to be a common feature of mutated proteins associated with both
ATS and BrS.
The metric of the PIM system is fundamentally an incidence matrix of 16 interactions. This
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incidence matrix can be reinterpreted as a 16–pseudo vector dual to 0–pseudo vector over a
Geometric algebra [24], and it would allow the construction of a bijection between incidence
matrices and real numbers (scalar). An important quality of this algebra is that its geometric product
ab = a∙b + a⌃ b acts in any linear vector space—it is not the case of the Gibbs algebra [25], whose
cross product a x b is restricted. Also this algebra can be programmed into parallel-processing
architectures, and although the PIM system is a supervised program when large files are analyzed,
e.g. the set of all ―reviewed‖ proteins from UniProt database (Table 1). The PIM elapsed time on the
computer is 24 hours, then the possible improvements that the PIM system can solve in the short
term are, the parallel processing techniques to reduce the processing time—when a master–slave
computational scheme is at play. The PIM system utilized in this study is based on this scheme. It
would be very helpful if the identification of the mutated proteins in the blood sample of the carrier
could be provided by a portable AArch64/A64 cluster, as this computational architecture is low-cost
and would enable the analysis of hundreds of proteins with the PIM system in a matter of seconds.
Another option would be to send the information to the ―cloud‖, where a parallel processor (i.e.
GPU-based cluster) could conduct the accelerated computation and deliver the answer back to the
mobile architecture. A cloud-based solution could also be useful to centralize data and associate them
with other geographical or temporal information that may help to study the disease from a population
distribution perspective [26].
In the long term, a portable microlaboratory is a step towards the personalized medicine, where
a portable unit can be close to the patient but still have the capacity of the big laboratory
infrastructure via the remote access. The identification of the number of mutated proteins associated
with the ATS in a given carrier is potentially possible through portable microlaboratories that can
access the ―fingerprint‖ of the mutated proteins associated with the ATS (microarrays) online. In
other words, it is not necessary for the portable microlaboratory to have its own microarray. Instead,
this electronic unit can (through wireless communication) have access to a remote microarray
database. This would reduce the production cost of these portable microlaboratories, making them
accessible to a wider population. Miniaturization may follow the philosophy of other personalized
medicine devices [27] and may conduct other analyses simultaneously.
5.

Conclusion

The efficiency of the Polarity Index Method® system aimed at the identification of Andersen–
Tawil mutated proteins makes it a useful bioinformatics tool, which can be used as a first filter in the
identification of this protein group, as well as other protein groups that the PIM system has identified [14].
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